Patrick Winders

Patrick Winders supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurement activities that enable public health surveillance, laboratory diagnostics, and biomedical research operations. He manages a diverse portfolio of acquisitions aligned with CDC’s strategic priorities, including analytical instrumentation, scientific consulting, and custom software development for epidemiological data systems. His work ensures timely access to advanced technologies and technical services essential for detecting, responding to, and mitigating infectious disease threats across the nation. Winders collaborates with a broad spectrum of vendors, including specialized analytical instrument manufacturers, scientific research consultants, and information technology firms delivering custom programming and data analytics solutions. While no single contractor dominates his award portfolio, his contracting patterns reflect a preference for competitive, open-market solicitations that prioritize technical capability, regulatory compliance, and scientific rigor. He frequently engages with firms capable of supporting high-complexity, low-volume procurements requiring stringent quality controls and rapid deployment timelines. His procurement approach is overwhelmingly focused on open competition, with 94.1% of acquisitions conducted without set-asides, reflecting the technical specificity and national security sensitivity of CDC’s requirements. Nevertheless, he maintains a deliberate, albeit modest, commitment to small business participation, consistently allocating approximately 5.9% of opportunities to small business set-asides, including 8(a) competed contracts, ensuring equitable access for qualified disadvantaged and socially and economically disadvantaged firms. Winders’ primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing) and 541690 (scientific and technical consulting services), reflecting CDC’s reliance on advanced diagnostic equipment and expert advisory support for outbreak response and public health infrastructure. He also oversees acquisitions in custom computer programming and physical sciences R&D, underscoring his technical expertise in data-driven public health systems, laboratory automation, and bioinformatics platforms critical to modern epidemiology.